Page last updated: 2024-09-05

lenalidomide and Cancer of Pelvis

lenalidomide has been researched along with Cancer of Pelvis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amann, A; Auer, T; Gamerith, G; Hilbe, W; Kircher, B; Loeffler-Ragg, J; Putzer, D; Schenk, B; Zwierzina, H	1

Other Studies

1 other study(ies) available for lenalidomide and Cancer of Pelvis

Article	Year
Increase in antibody-dependent cellular cytotoxicity (ADCC) in a patient with advanced colorectal carcinoma carrying a KRAS mutation under lenalidomide therapy. Cancer biology & therapy, 2014, Mar-01, Volume: 15, Issue:3 Topics: Adenomatous Polyposis Coli; Adult; Angiogenesis Inhibitors; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Humans; Killer Cells, Natural; Lenalidomide; Liver Neoplasms; Lung Neoplasms; Mutation; Pelvic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Thalidomide	2014

Article

Year

Increase in antibody-dependent cellular cytotoxicity (ADCC) in a patient with advanced colorectal carcinoma carrying a KRAS mutation under lenalidomide therapy.

Cancer biology & therapy, 2014, Mar-01, Volume: 15, Issue:3

Topics: Adenomatous Polyposis Coli; Adult; Angiogenesis Inhibitors; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Humans; Killer Cells, Natural; Lenalidomide; Liver Neoplasms; Lung Neoplasms; Mutation; Pelvic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Thalidomide

2014